Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension by Hanny Al‐Samkari, Srikanth Nagalla

Get full text

Romiplostim for PARP inhibitor-induced thrombocytopenia in solid tumor malignancies by Abraham Z. Cheloff, Hanny Al‐Samkari

Get full text

Optimal use of thrombopoietin receptor agonists in immune thrombocytopenia by Hanny Al-Samkari, David J. Kuter

Get full text

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis by Hanny Al-Samkari, Jean M. Connors

Get full text

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients by Orly Leiva, Jean M. Connors, Hanny Al-Samkari

Get full text

The role of romiplostim for pediatric patients with immune thrombocytopenia by Hanny Al-Samkari, Rachael F. Grace, David J. Kuter

Get full text

Serum complement levels in immune thrombocytopenia: Characterization and relation to clinical features by Abraham Z. Cheloff, David J. Kuter, Hanny Al‐Samkari

Get full text

Response to rituximab in children and adults with immune thrombocytopenia (ITP) by Emily M. Harris, Kirsty Hillier, Hanny Al‐Samkari, Laura Berbert, Rachael F. Grace

Get full text

Systemic bevacizumab for high-output cardiac failure in hereditary hemorrhagic telangiectasia: an international survey of HHT centers by Hanny Al-Samkari, Hasan A. Albitar, Scott E. Olitsky, Marianne S. Clancy, Vivek N. Iyer

Get full text

P1477: MITAPIVAT EFFICACY IN ADULTS WITH PYRUVATE KINASE DEFICIENCY AND BASELINE HEMOGLOBIN LEVELS >10 G/DL by Rachael F. Grace, Janet Kwiatkowski, Eduard van Beers, Feng Tai, Bryan Mcgee, Hanny Al-Samkari

Get full text

The efficacy and safety of thrombopoietin receptor agonists in patients with chronic liver disease undergoing elective procedures: a systematic review and meta-analysis by Ingrid Lindquist, Sven R. Olson, Ang Li, Hanny Al‐Samkari, Janice H. Jou, Owen J. T. McCarty, Joseph J. Shatzel

Get full text

Mortality among US veterans with a physician-documented diagnosis of pyruvate kinase deficiency by Erin Zagadailov, Hanny Al-Samkari, Audra N. Boscoe, Bryan McGee, Sherry Shi, Dendy Macaulay, Lizheng Shi, Viviana Garcia-Horton

Get full text

PB2636: VAYHIT1: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VERSUS PLACEBO IN ADDITION TO FIRST-LINE CORTICOSTEROIDS IN PATIENTS WITH PRIMARY IMMUNE THRO... by Nichola Cooper, Adam Cuker, Marc Michel, Raymond Wong, Waleed Ghanima, Francesco Zaja, Wilma Barcellini, Fengkui Zhang, Tomasz Lawniczek, Marine Weill, Hanny Al-Samkari

Get full text

PB2625: VAYHIT2: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL OF IANALUMAB VS PLACEBO IN ADDITION TO ELTROMBOPAG IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA (ITP) WHO FAILED FI... by Francesco Zaja, Hanny Al-Samkari, Marc Michel, Waleed Ghanima, Nichola Cooper, Raymond Wong, Wilma Barcellini, Fengkui Zhang, Emerenziana Marturano, Severine Peyrard, Adam Cuker

Get full text

PB2552: VAYHIA: A RANDOMIZED, DOUBLE-BLIND, PHASE III TRIAL TO ASSESS THE EFFICACY AND SAFETY OF IANALUMAB VS PLACEBO IN PATIENTS WITH WARM AUTOIMMUNE HEMOLYTIC ANEMIA THAT FAILED... by Wilma Barcellini, Marc Michel, Adam Cuker, Nichola Cooper, Waleed Ghanima, Raymond Wong, Francesco Zaja, Fengkui Zhang, Vladimir Bezlyak, Thu Thuy Nguyen, Hanny Al-Samkari

Get full text

P1497: MITAPIVAT IMPROVES IRON OVERLOAD IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY WHO ARE REGULARLY TRANSFUSED by Eduard van Beers, Hanny Al-Samkari, Rachael F. Grace, Wilma Barcellini, Andreas Glenthøj, Vanessa Beynon, Megan Wind-Rotolo, Rengyi Xu, Melissa Dibacco, Parija Patel, John B. Porter, Kevin H.M. Kuo

Get full text

S302: LONG-TERM SAFETY AND EFFICACY OF EFGARTIGIMOD IN PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA: INTERIM RESULTS OF THE ADVANCE+ STUDY by Monica Carpenedo, Catherine M Broome, Vickie Mcdonald, Yoshitaka Miyakawa, David Kuter, Hanny Al-Samkari, James Bussel, Filip Matthijssens, Anna Hultberg, Jaume Ayguasanosa Dachs, Kristof De Beuf, Francesco Rodeghiero, Marc Michel, Adrian Newland

Get full text

Patients with myeloproliferative neoplasms and COVID‐19 have increased rates of arterial thrombosis by Orly Leiva, Umberto Campia, Julia Snyder, Briana M. Barns, Samantha Rizzo, Candrika D. Khairani, Andrew Brunner, Hanny Al‐Samkari, Rebecca Karp Leaf, Rachel Rosovsky, Katayoon Goodarzi, Larissa Bornikova, Amir Fathi, Samuel Z. Goldhaber, Gabriela Hobbs, Gregory Piazza

Get full text

P1473: CLINICALLY RELEVANT HEMOGLOBIN RESPONSE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY TREATED WITH MITAPIVAT – A SUB-ANALYSIS OF THE ACTIVATE TRIAL by Hanny Al-Samkari, Rachael F. Grace, Andreas Glenthøj, Wilma Barcellini, Madeleine Verhovsek, Jennifer A. Rothman, Marta Morado, Mark Layton, Oliver Andres, Frédéric Galactéros, Koichi Onodera, Satheesh Chonat, Rengyi Xu, Bryan Mcgee, Melissa Dibacco, Jaime Morales, Eduard van Beers

Get full text